Vivani Medical Files 8-K
Ticker: VANI · Form: 8-K · Filed: Jul 11, 2024 · CIK: 1266806
Sentiment: neutral
Topics: 8-K, filing, corporate-update
TL;DR
Vivani Medical filed an 8-K on 7/11/24. Standard update.
AI Summary
Vivani Medical, Inc. filed an 8-K on July 11, 2024, reporting other events and financial statements. The company, formerly known as Second Sight Medical Products Inc., is incorporated in Delaware and headquartered in Alameda, California.
Why It Matters
This filing indicates Vivani Medical is providing updates on its corporate activities and financial status to the SEC.
Risk Assessment
Risk Level: low — This is a routine filing of an 8-K, which typically reports significant events or financial updates without immediate market-moving implications on its own.
Key Players & Entities
- Vivani Medical, Inc. (company) — Registrant
- July 11, 2024 (date) — Date of earliest event reported
- Second Sight Medical Products Inc. (company) — Former company name
- 1350 S. Loop Road Alameda, California 94502 (location) — Principal executive offices address
FAQ
What is the primary purpose of this 8-K filing for Vivani Medical, Inc.?
The 8-K filing on July 11, 2024, reports on 'Other Events' and 'Financial Statements and Exhibits' for Vivani Medical, Inc.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on July 11, 2024.
What was Vivani Medical, Inc.'s former company name?
Vivani Medical, Inc.'s former company name was Second Sight Medical Products Inc.
Where are Vivani Medical, Inc.'s principal executive offices located?
Vivani Medical, Inc.'s principal executive offices are located at 1350 S. Loop Road, Alameda, California 94502.
Under which state is Vivani Medical, Inc. incorporated?
Vivani Medical, Inc. is incorporated under the state of Delaware.
Filing Stats: 472 words · 2 min read · ~2 pages · Grade level 10.1 · Accepted 2024-07-11 08:15:29
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share VANI Nasdaq Capital Mark
Filing Documents
- g084331_8k.htm (8-K) — 35KB
- g084331_ex99-1.htm (EX-99.1) — 15KB
- 0001753926-24-001236.txt ( ) — 222KB
- vani-20240711.xsd (EX-101.SCH) — 3KB
- vani-20240711_lab.xml (EX-101.LAB) — 33KB
- vani-20240711_pre.xml (EX-101.PRE) — 22KB
- g084331_8k_htm.xml (XML) — 3KB
Financial Statements and
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press release issued by Vivani Medical, Inc. on July 11, 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. VIVANI MEDICAL, INC. Date: July 11, 2024 By: /s/ Brigid A. Makes Name: Brigid A. Makes Title: Chief Financial Officer